Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the Bladder.

Saved in:
Bibliographic Details
Title: Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the Bladder.
Authors: Ślusarczyk A; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland. Electronic address: slusarczyk.aleksander@gmail.com., Scilipoti P; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Contieri R; Department of Urology, Istituto Nazionale Tumori di Napoli IRCCS Fondazione 'G. Pascale', Napoli, Italy., Longoni M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., de Angelis M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Miszczyk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum-Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Krajewski W; Department of Urology and Oncologic Urology, Wrocław Medical University, Wroclaw, Poland., Laukthina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Del Giudice F; Department of Maternal Infant and Urologic Sciences, Sapienza University, Umberto I Polyclinic Hospital, Rome, Italy., Gallioli A; Department of Urology, Puigvert Foundation, Autonomous University of Barcelona, Barcelona, Spain., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Surgery and Interventional Sciences, University College London and University College London Hospital, London, UK; Second Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland., Pradere B; Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, France., Shah P; Department of Urology, Mayo Clinic, Rochester, MN, USA., Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN, USA., Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Radziszewski P; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Oct; Vol. 23 (5), pp. 102399. Date of Electronic Publication: 2025 Jul 05.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2025.102399